A new review highlights the future of anti-obesity medications that could outperform today's already blockbuster drugs like ...

Obesity management drugs are evolving from once-weekly GLP-1 receptor agonist injections to longer-acting candidates, ...

From once-weekly subcutaneously injectable medicines agonizing the glucagon-like peptide 1 receptor (GLP-1R), longer-acting ...

JPMorgan event follows the murder of an industry leader and the nomination of a vaccine sceptic as top official ...